Company Spotlight

Cytovance Biologics

800 Research Pkwy., Suite 200
Oklahoma City, OK 73104
United States
View Profile

Adare Pharmaceuticals

1200 Lenox Drive
Princeton Pike Corporate Center, Suite 100
Lawrence Township, NJ 08648
United States
View Profile

Aphena Pharma Solutions, Inc.

1920 Fisk Road
Cookeville, TN 38506
United States
View Profile


Contract Service Directory


Comprehensive Clinical Development





Company Headquarters

3100 SW 145th Avenue, Suite 340
Miramar, Florida 33027
United States

Contract Service Directory

    Related Content

    • Drug Development
      Solving the Pharma Talent Crunch

      Solving the Pharma Talent Crunch

      Addressing talent shortages in today's pharmaceutical sector
      Jim Sykes, Managing Director, Pharmaceutical & Life Sciences, Alexander Mann Solutions 05.30.17

    • Promotions & Moves

      Akebia Therapeutics Names CMO

      Jain to lead clinical development of the company’s HIF pipeline
      05.25.17

    • Biologics, Proteins, Vaccines | Breaking News | Collaborations & Alliances | Drug Development | Industry News
      Selexis SA and OSE Immunotherapeutics Enter Pact

      Selexis SA and OSE Immunotherapeutics Enter Pact

      Sign agreement for the development of OSE's interleukin receptor 7 antagonist
      05.24.17


    • Clinical Trials | CRO News | Information Technology
      CROS NT Expands Medidata Pact

      CROS NT Expands Medidata Pact

      Will offer customers Medidata’s next-gen EDC and RTSM systems
      05.23.17

    • Industry News
      Worldwide Clinical Trials Appoints Clinical Ops VP

      Worldwide Clinical Trials Appoints Clinical Ops VP

      Nowatkoski brings extensive senior clinical operations
      05.23.17

    • Breaking News | Clinical Trials | CRO News | GMPs/GCPs

      CRA Acquires Comprehensive Clinical Late Phase Unit

      Expands geographic and therapeutic reach
      07.25.13


    • Breaking News | Clinical Trials | GMPs/GCPs

      Comprehensive Expands Headquarters

      New facility allows for further expansion and future growth
      08.03.11